HRT Financial’s Applied UV, Inc. Common Stock AUVI Stock Holding History

HRT Financial’s Portfolio AUVI Stock Details AUVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,140	Closed	-$9K	–	3325
2023 Q3	$9K	Buy	+1,140	New	+$19.1K	﹤0.01%	2137
2021 Q3	–	Sell	-101	Closed	-$124K	–	3908
2021 Q2	$124K	Buy	+101	New	+$117K	﹤0.01%	2539

Other funds holding AUVI

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HRT Financial's AUVI Position: Q4 2023 in Review

HRT Financial sold out of Applied UV, Inc. Common Stock (AUVI) in Q4 2023, closing a stake of 1,140 shares — an estimated $9K sold.

HRT Financial first reported a position in AUVI in Q2 2021 and held it in 2 quarters. The position peaked at $124K in Q2 2021. 5 funds tracked by Wall St. Rank hold AUVI as of Q4 2023.

HRT Financial reported no remaining Applied UV, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
HRT Financial sold 1,140 Applied UV, Inc. Common Stock shares in Q4 2023, an estimated $9K.
HRT Financial first reported a position in Applied UV, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
HRT Financial's Applied UV, Inc. Common Stock position peaked at $124K in Q2 2021.
5 funds tracked by Wall St. Rank held Applied UV, Inc. Common Stock as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.